Form 8-K - Current report:
SEC Accession No. 0001437749-26-015945
Filing Date
2026-05-08
Accepted
2026-05-08 17:00:16
Documents
12
Period of Report
2026-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K iccc20260508_8k.htm   iXBRL 8-K 23246
  Complete submission text file 0001437749-26-015945.txt   152260

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA iccc-20260508.xsd EX-101.SCH 3578
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iccc-20260508_def.xml EX-101.DEF 11423
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iccc-20260508_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iccc-20260508_pre.xml EX-101.PRE 11583
15 EXTRACTED XBRL INSTANCE DOCUMENT iccc20260508_8k_htm.xml XML 2832
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 26959447
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)